Table 3.
Between-group analysis of different outcome measures at 4th, 8th and 12th week.
| Measures | Quetiapine N = 25 | Aripiprazole N = 25 | t | p value | Df | 95% CI |
|---|---|---|---|---|---|---|
| SAPS 4th week | 58.36 ± 4.84 | 57.02 ± 3.71 | 1.099 | 0.27 | 48 | −1.11, 3.79 |
| SAPS 8th week | 57.19 ± 3.65 | 56.43 ± 3.28 | 0.774 | 0.44 | 48 | −1.21, 2.73 |
| SAPS 12th week | 56.79 ± 3.74 | 55.97 ± 3.23 | 0.830 | 0.41 | 48 | −1.17, 2.81 |
| SANS 4th week | 44.58 ± 2.96 | 45.92 ± 3.53 | −1.454 | 0.15 | 48 | −3.19, 0.51 |
| SANS 8th week | 43.99 ± 3.38 | 45.01 ± 4.03 | −0.970 | 0.33 | 48 | −3.14, 1.10 |
| SANS 12th week | 43.62 ± 2.79 | 44.51 ± 3.49 | −0.996 | 0.32 | 48 | −2.69, 0.91 |
| SAI 12th week | 3.01 ± 0.11 | 2.90 ± 0.39 | 1.357 | 0.18 | 48 | −0.05, 0.27 |
| SAS 12th week | 0.35 ± 0.11 | 0.38 ± 0.09 | −1.055 | 0.29 | 48 | −0.09, 0.03 |
| CGI-S 12th week | 3.20 ± 1.01 | 3.14 ± 1.03 | 0.208 | 0.83 | 48 | −0.52, 0.64 |
CGI-S, Clinical Global Impressions Severity Scale; CI, confidence interval; SAI, Schedule for Assessment of Insight; SANS, Scale for Assessment of Negative Symptoms; SAPS, Scale for Assessment of Positive Symptoms; SAS, Simpson Angus Scale.